FDA Advisory Panel Rejects Pfizer’s Widespread Booster Injection

WASHINGTON (AP) – An influential federal advisory group has vehemently rejected a plan to offer Pfizer vaccines against COVID-19 to most Americans.

Friday’s 16-2 vote was a blow to the Biden administration’s efforts to strengthen human defenses against the virus, amid the highly contagious delta variant.

Over the course of several hours of discussion, FDA external panelists expressed disappointment that Pfizer had provided little data on the safety of additional doses.

And they complained that the data provided by Israeli researchers on their booster campaign might not be appropriate to predict the US experience.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button